Beyond Hair Styling: Stylists As HIV PrEP Messengers
Duke researchers tested a program that involves hair stylists in raising awareness, possible uptake of HIV preexposure prophylaxis (PrEP) among Black women, a group that is disproportionately affected by new HIV infections.
FDA Updates for the Week of Feb 19: Cancer Approval Revoked
The FDA has removed the approval of Pepaxto in multiple myeloma. The agency approved Amtagvi, the first TIL therapy for a solid tumor, as well a new biweekly dosing of Tecvayli for multiple myeloma. The agency has set actions for several products, including a first-in-class lung cancer therapy, a bispecific antibody for advanced multiple myeloma, and another for Dupixent for COPD
Sanjula Jain Urges a Comprehensive Approach in Address Alarming Rise in Cancer Cases Among Younger Populations
In this month’s episode of Tuning In to the C-Suite, Briana Contreras, an editor of Managed Healthcare Executive, got to chatting with Sanjula Jain, Ph.D., chief research officer at Trilliant Health.
UnitedHealth Unplugs Change Healthcare Information Systems To Contain Cyber Attack
The information systems of Change Healthcare, a recently acquired subsidiary of UnitedHealth Group, were disconnected on Wednesday.
Results: MHE Question of the Week #4
The results of this week’s poll about Medicaid work requirements.
CAR T-cell Therapy Shows 6-Year Durability in CLL Patients
A study suggests that a novel CAR T-cell therapy could be a curative treatment for some patients with chronic lymphocytic leukemia, with 25% of responders still in remission after 6 years.
Potential Urology Drug Savings Through Mark Cuban Drug Company
The greatest savings are seen for 90-tablet prescriptions.
Smoking and Certain Mutations Are Risks For Lung Cancer. But Your Immune System’s Ability to Ferret Out Early Cancer May Be Another One, Researchers Find
Research results reported in the journal Science today add to the evidence that “immunogenetics” likely influences people’s susceptibility to developing lung cancer, especially among smokers.
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Women Leaders Rally and Urge Health Insurers to Comply with ACA Birth Control Coverage
A coalition of women, including members of the Democratic Women’s Caucus (DWC), Pro-Choice Caucus Contraception & Family Planning Task Force, and Senators, took the lead in rallying over 150 House and Senate Democratic colleagues, after the large group of lawmakers wrote a letter yesterday to America’s Health Insurance Plans (AHIP) President and CEO Mike Tuffin addressing that AHIP’s “members are not complying with the Affordable Care Act contraception coverage requirement.."
A Quarter of Public Sector Health Plan Spending Goes Toward Covering Specialty Drug Costs
Because of expensive specialty drugs, pharmacy expenditures accounted for one-quarter of healthcare spending by public sector health plans, according to a new report by two public sector health plan groups.
Healthcare Organizations Support Digital Health Collaborative's Initiative to Advance Digital Health Solutions
This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
Biopharma R&D Funding Has Rebounded But Clinical Trial Starts Slowed Down in 2023, Says IQVIA Institute
Research and development funding increased in 2023 but clinical trial starts fell by 15%, partly because of fewer COVID-19-related trials, according to IQVIA's worldwide report on research and development in the biopharmaceutical industry.
Relationship Discovered Between Sleep Characteristics and Gut Microbiota
New insight could change the way physicians treat disorders like insomnia.
Fecal Transplant Therapies Recommended for Recurrent C. difficile in Some Patients
Official recommendations from the American Gastroenterological Association.
Top 10 Largest Healthcare Security Breaches of 2023
There was a record-breaking total of 725 breaches in 2023.
Heart Attack Linked to Higher Risk of Other Health Conditions
Heart failure, renal failure, atrial fibrillation and death are among the events that can happen years after a myocardial infarction.
Droughts May Trigger HIV Spread in Rural Sub-Sahara Africa
It’s likely droughts will become more common due to climate change.
Healthcare Leaders See AI Playing a Role in Future
Majority of leaders think AI will help them expand the capabilities of healthcare.
HHS Needs More Rebate Information To Negotiate Medicare Drug Prices, Say USC Experts
The Health and Human Services department could wind up overpaying (or possibly underpaying) for the drugs for which it is negotiating a “maximum fair price” for Medicare under the Inflation Reduction Act, argue experts at the USC Schaeffer Center for Health Policy and Economics. A fuller picture of rebates and net prices could help that from happening, they say.
MHE Question of the Week: Do You Favor Medicaid Work Requirements?
Do you favor Medicaid work requirements?
Cataract Surgery: It Is More Than Just Your Vision That Improves
Researchers have identified an association between cataract surgery and a lower risk of cognitive decline and dementia.
Contract Management in a Value-Based Care Environment
For operational efficiency, value-based initiatives need a scalable digital infrastructure that can handle multiple reimbursement models, including fee for service.
FDA Updates for the Week of Feb. 12, 2024: New Approvals, an Extended Review and Goal Dates Set
The FDA approves Eohilia for eosinophilic esophagitis and Onivyde for metastatic pancreatic cancer but extends review of gene therapy for rare immune disorder. The agency also set goal dates for three products: full approval for Elevidys, Augtyro for solid tumors with NTRK gene fusions and seladelpar as for rare liver disease.
Results: MHE Question of the Week #3
The results of this week’s poll about Super Bowl LVIII commercials.
Japan Approves Dupixent for Chronic Spontaneous Urticaria (CSU) Becoming First in the World to Do So
This makes CSU treatment the sixth approved use globally.
New Federal Rule Overhauls Health Insurers' Prior Authorization Processes
The rule comes as health insurers have increasingly been criticized for onerous and time-consuming prior authorization procedures that physicians say unfairly delay or deny the medical treatment that their patients need.
First-of-its-Kind Study Reveals Accelerated Aging in Women with HIV
GoodRx Releases List of 30 Heart Medications Under $30
The cheapest medication on the list is hydrochlorothiazide at $4.55.
SkinCure Oncology Secures Patent for Innovative Image-Guided Technology in Nonmelanoma Skin Cancer Treatment
SkinCure Oncology has not yet submitted its data to the FDA for marketing clearance, however once cleared, the new devices will use hybrid laser-generated confocal and photoacoustic imaging in a single fused volumetric image.
2 Commerce Drive Cranbury, NJ 08512